Aurobindo Pharma reports Q1 financial results showing profit growth alongside higher revenue. According to NDTV, the company’s revenue for the quarter is Rs 9,150 crore. NDTV also states that this figure is compared with Rs 7,868 crore in the preceding financial year, indicating revenue growth during the period. The company’s profit rises by 25% year-on-year, NDTV reports, with margins improving as part of the same results announcement. The coverage focuses on the company’s top-line performance, profit increase, and margin improvement during the quarter. Overall, the reported figures point to stronger profitability compared with the prior year period, while revenue remains within the reported Rs 9,150 crore level for the quarter. The reports do not provide additional operational details such as segment performance, guidance, or investor commentary beyond the headline financial metrics.